HaploX Stock

haplox.cnBioTechFounded: 2014Funding to Date: $42.87MM

HaploX aims to integrate liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies to improve the management of cancer patients.

Register for Details

For more details on financing and valuation for HaploX, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Yan Ming Xu Ph.D
Co-Founder, Chief Executive Officer & Chairman
Wen Yuan
Chief Financial Officer & Co-Founder
Fang Wen
Chief Operating Officer & Co-Founder
Chen Shifu Ph.D
Chief Technology Officer & Co-Founder

Board Members

Yan Ming Xu Ph.D

Other companies like HaploX in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

A group of investors including SBCVC and Kexin Capital have backed a $32 million funding round for China’s HaploX Biotechnology. ,Greater China,Healthcare,Technology,Early-stage ,China,Softbank China Venture Capital,Venture